Pan Shen Liang Han Xin Ba Kai Qin Shenghao Tu
10.3389/fphar.2021.678409
Front Pharmacol
2021 Jul 5;12:678409.
hyperprogressive disease immune checkpoint inhibitors immunotherapy predictive biomarker pseudoprogression
CC BY
https://pubmed.ncbi.nlm.nih.gov/34290608/
Review
PMC8287409
34290608
Hyperprogressive Disease in Cancers Treated With Immune Checkpoint Inhibitors
2021